Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at imatinib (Glivec) for children and young people with acute lymphoblastic leukaemia (EsPhALL trial)

Overview

Cancer types:

Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Children's cancers, Leukaemia

Status:

Results

Phase:

Phase 2

Details

This trial looked at imatinib (Glivec) for children and young people with Philadelphia positive acute lymphoblastic leukaemia (ALL).

Recruitment start: 1 June 2004

Recruitment end: 31 December 2009

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Vaskar Saha

Supported by

Bloodwise

Central Manchester University Hospitals NHS Foundation Trust

Children's Cancer and Leukaemia Group (CCLG)

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Last reviewed: 08 Aug 2016

CRUK internal database number: 492

Help and support